NSN 6505-01-477-6768 · NIIN 014776768 · FSC 6505
NO DASHES 6505014776768
In Stock
RETAPLASE,RECOMBINANT FOR INJECT
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | RETEPLASE, INTRAVENOUS SOLUTION KIT, 2 VIALS(10 UNITS PER VIAL) |
| FEAT | SPECIAL FEATURES | RETAVASE IS A TISSUE PLASMINOGEN ACTIVATOR (TPA) INDICATED FOR TREATMENT OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) TO REDUCE THE RISK OF DEATH AND HEART FAILURE; LYOPHILIZED POWDER KIT FOR IV INJECTION; CONTAINS: 2 SINGLE-USE RETAVASE 10-UNIT VIALS; 2-SINGLE-USE PREFILLED STERILE WATER FOR INJECTION; 2 SYRINGE PLUNGERS; 2 STERILE 10ML GRADUATED SYRINGES; 2 STERILE RECONSTITUTION SPIKES; 1 QUICK REFERENCE GUIDE AND 1 PACKAGE INSERT; BOX SHOULD REMAIN SEALED TO PROTECT THE LYOPHILISATE FROM EXPOSURE TO LIGHT. STORE KIT AT 2 TO 25 DEGREES CELSIUS. |
Cross-references
6 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| NDC10122-0141-02 | 1XUY5 |
| 817783 | 1XUY5 |
| RETAVASE KIT | 4YZ75 |
| NDC10122-0141-02 | 4YZ75 |
| 6505NCM206364 | 64616 |
| 1578957 | 89875 |